News

Xequel Bio, Inc. Appoints Veteran Pharmaceutical Executives to Advance Next Stage of Corporate Growth

Jerry St. Peter Named Chief Executive Officer and Member of the Board of Directors Wes Brazell Named Chief Financial Officer Executives Bring Significant Global Biopharmaceutical Development and Commercial Expertise New Corporate Name Launches Strategic Evolution to Late-Stage Development Charleston, SC and Fort Worth, TX, May 11, 2022 -- Xequel Bio,...